Companies / Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc.

Nasdaq: XBIOCIK 1534525FRAMINGHAM, MAxeneticbio.com

Financials · FY2025

Revenue$2.98M
Net income$-2.68M
Total debt$212.8K
Cash
Diluted EPS$-1.58
Shares outstanding2.3M

Ownership

2.3M shares outstanding · as of Jul 31, 2026
4.3%Insiders
Ownership
Insiders4.27%100,000
10%+ / strategic7.62%178,509
Institutions2.49%58,369
Public float85.62%2,006,303

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Parslow James FCEOInterim CEO and CFO
4.27%100,000

Institutional holders 12

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 21, 2026Parslow James F
CEO
GrantCommon Stock$0+100K
100,000
4.27% of shares
low
Dec 31, 2025Borisenko Grigory G.
Director
GrantStock Options+3K
2,500
0.11% of shares
low
Dec 31, 2025Vinogradov Alexey Andreevich
Director
GrantStock Options+3K
2,500
0.11% of shares
low
Dec 31, 2025Dastoor Firdaus J.
Director
GrantStock Options+3K
2,500
0.11% of shares
low
Dec 31, 2025Kornberg Roger D.
Director
GrantStock Options+3K
2,500
0.11% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Renaissance Technologies LLCPassive13G178,509
Renaissance Technologies LLCPassive13G/A137,440

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
XBIO984015602